To view this email as a web page, click here.
 
TOP STORIES
 
Oncology Pipeline Predictions
This year has been another year full of oncology approvals, proving that the oncology pipeline is robust with first-of-the kind molecules, competitor products for existing agents, and biosimilars.
Read more
ADVERTISEMENT
 
Eight Top Oncology Drug Approvals
New cancer drugs continue to offer patients hope. Here are eight of them.
Read more
ADVERTISEMENT
 
The Most Troubling Part of Cancer Treatment for Patients
A Wamberg Genomic Advisors' Cancer Survey has revealing findings from people dealing directly with cancer.
Read More
 
DIGITAL EDITION
Check out our October issue featuring:
 • Healthcare Disruptors
 • PBMs and Performance-based Neworks
 • Build a Pipeline of Future Leaders
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.